Therapeutic Potential of Metabolites from Lactobacillus rhamnosus and Mare’s Milk in the Treatment of Dysbiosis

Table 1

Inhibitory activity of L. rhamnosus and L. rhamnosus cell-free lysate against test strains.

Test strains	L. rhamnosus	L. rhamnosus cell-free lysate
Escherichia coli NCTC 12241/ATCC® 25922™	28 mm (+++)	21 mm (++)
Salmonella typhimurium NCTC 12023/ATCC® 14028™	25 mm (+++)	19 mm (++)
Helicobacter pylori ATCC 43504	17 mm (++)	12 mm (+)
Staphylococcus aureus NCTC 12973/ATCC® 29213™	18 mm (++)	12 mm (+)
Candida albicans NCPF 3179/ATCC® 10231™	15 mm (+)	11 mm (+)

, 11-16 mm, 17-22 mm, and >23 mm were classified as negative (-), mild (+), strong (++), and very strong (+++) inhibitors, respectively.